Evidence map›Paper›PMID 39826708›Full record

ArticleJournal of molecular biology2025

Differences in Binding Affinity Among Cell-cycle CDK and Cyclin Pairs.

Sivasankar Putta, Carina A Villegas, Seth M Rubin

Abstract read
In one paragraph

Article in Journal of molecular biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sivasankar PuttaDepartment of Chemistry and Biochemistry, University of California, Santa Cruz, CA, United States.
Carina A VillegasDepartment of Chemistry and Biochemistry, University of California, Santa Cruz, CA, United States.
Seth M RubinDepartment of Chemistry and Biochemistry, University of California, Santa Cruz, CA, United States. Electronic address: srubin@ucsc.edu.

Funding

Project 3: Defining and targeting mechanisms of E2F transcription factor regulationP01CA254867 · NCI · STANFORD UNIVERSITY · PI Seth Michael Rubin, Jan M Skotheim · 2022 to 2026
$8.9M
Molecular Mechanisms of Cell Cycle Dependent Gene ExpressionR35GM145255 · NIGMS · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI Seth Michael Rubin · 2022 to 2026
$3.0M
An Octet Bio-layer Interferometer for Macromolecular Interaction Studies at UCSCS10OD027012 · OD · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI RUBIN, SETH MICHAEL · 2019 to 2019
$370k
NCI NIH HHS P01 CA254867NIGMS NIH HHS R35 GM145255NIH HHS S10 OD027012
6 · The paper itself

Abstract

The mammalian cell cycle is coordinated by primarily four cyclin-dependent kinases (CDKs), which are activated by a family of cyclin proteins to phosphorylate diverse protein effectors of cell growth and division. A wealth of qualitative protein interaction studies have supported a model in which different CDKs have specific cognate cyclin partners. However, there have been few quantitative measurements of binding kinetics and affinity to support our understanding of CDK-cyclin preferences and the structural origins of those preferences. We used a biolayer interferometry (BLI) assay to quantify association and dissociation rates and to determine binding constants for all pairings of the cell-cycle CDKs and cyclins. We found that the highest affinity interactions, including CDK1 for CycB, CDK2 for CycA and CycE, and CDK4 for CycD, involve complexes that are considered canonical and have most often been reported. Structural modeling and mutagenesis experiments demonstrate that specific sequence differences can explain preferential interactions in the case of CDK2 binding to CycA compared to CycD. Finally, we show that all the cell-cycle CDK-cyclin complexes are competent to catalyze ATP phophotransfer with only a few outliers demonstrating relatively high or low catalytic efficiency. The implications of these observations for the potential activation of noncanonical CDK-cyclin pairs in cancer cell proliferation are discussed.

Indexed as

Cell CycleCyclin-Dependent KinasesCyclinsCyclin-Dependent Kinase 2HumansKineticsModels, MolecularProtein BindingCDK2 protein, humanCyclin-Dependent Kinase 2Cyclin-Dependent KinasesCyclinsbilayer interferometrycell cyclekinasesprotein–protein interactions

Identifiers

PMID39826708
PMCPMC12182275

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.